IP Group
Biotech Investor · 4 portfolio companies
Portfolio
4
Focus Areas
6
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Crescendo Biologics | — |
| Enterprise Therapeutics | — |
| SignaCor | — |
| The Bland Company | — |
Biotech Investor · 4 portfolio companies
| Company | Valuation |
|---|---|
| Crescendo Biologics | — |
| Enterprise Therapeutics | — |
| SignaCor | — |
| The Bland Company | — |